Comparative oncology in action: vignettes on immunotherapy development.

Area of Science:

• Comparative oncology
• Immunotherapy
• Cancer research

Background:

• Immunotherapies, including immune checkpoint inhibitors and T cell-based therapies, have shown significant success in cancer treatment.
• Comparative oncology studies naturally occurring cancers in companion animals, primarily dogs, offering a valuable model for cancer research and drug development.
• Tumor-bearing pet dogs possess intact immune systems and naturally co-evolved tumor microenvironments, making them suitable for exploring cellular interactions and novel therapeutics.

Purpose of the Study:

• To explore cellular interactions and test novel immunotherapeutic approaches in tumor-bearing pet dogs.
• To leverage the similarities between canine and human immune systems for assessing various immunotherapeutic strategies.
• To provide examples of how canine immunotherapeutic studies have informed human treatment approaches.

Main Methods:

• Assessment of diverse immunotherapeutic approaches, including antibody therapies, tumor vaccines, and cell-based therapies, in canine models.
• Combination of immunotherapies with conventional treatments like chemotherapy and radiotherapy.
• Emphasis on study design, correlative immune assay development and application, and definition of biologic effect in canine studies.

Main Results:

• Canine studies provide a platform for evaluating the efficacy and safety of various immunotherapeutic strategies.
• The development and application of correlative immune assays in dogs help elucidate treatment mechanisms.
• Biologic effects observed in canine trials inform the translation of these approaches to human cancer patients.

Conclusions:

• Comparative oncology in pet dogs is a powerful tool for advancing cancer immunotherapy research.
• Canine studies offer unique insights into immune system interactions and therapeutic responses, guiding the development of human cancer treatments.
• The findings underscore the importance of well-designed studies and robust correlative assays in translating preclinical findings to clinical applications.